There are 360 resources available
114P - Systemic Inflammatory Index as a prognostic biomarker in metastatic melanoma patients under immune checkpoint inhibitors
Presenter: Mariana Rebordão Pires
Session: Poster Display
115P - Reflectance Confocal Microscopy - An In Vivo Method Of Visualization Of NMSC Under Anti-PD-1 Therapy In Correlation To Histological Findings - Preliminary Report
Presenter: Iwona Lugowska
Session: Poster Display
116P - Clinical Significance of Serum-derived Exosomal PD-L1 Expression in Patients with Advanced Pancreatic Cancer
Presenter: Se Jun Park
Session: Poster Display
117P - Beta-Blockers in Lung Cancer Patients Receiving Immunotherapy
Presenter: Ana Mendes
Session: Poster Display
118P - Immunosenescence and response to immunotherapy in elderly patients: A possible prognostic tool
Presenter: Andrea Pretta
Session: Poster Display
119TiP - An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG)
Presenter: Christian Gessner
Session: Poster Display
120TiP - Conversion of Response to Immune Checkpoint Inhibition by Fecal Microbiota Transplantation in Patients With Metastatic Melanoma: a Randomized Phase Ib/IIa Trial
Presenter: Jessica Borgers
Session: Poster Display
201P - Phase II study of taminadenant (A2AR antagonist) + spartalizumab (anti PD-1 antibody) in patients with triple negative breast cancer (TNBC)
Presenter: Guy Jerusalem
Session: Poster Display
202P - The therapeutic cancer vaccine PDC*lung01 induces immune responses with or without anti- PD-1 treatment in patients with non-small cell lung cancer
Presenter: Anne Sibille
Session: Poster Display